Fabiola Torres-Skair v. Medco Health Solutions of Hidden River, LC

595 F. App'x 847
CourtCourt of Appeals for the Eleventh Circuit
DecidedDecember 4, 2014
Docket13-14476
StatusUnpublished
Cited by3 cases

This text of 595 F. App'x 847 (Fabiola Torres-Skair v. Medco Health Solutions of Hidden River, LC) is published on Counsel Stack Legal Research, covering Court of Appeals for the Eleventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Fabiola Torres-Skair v. Medco Health Solutions of Hidden River, LC, 595 F. App'x 847 (11th Cir. 2014).

Opinion

PER CURIAM.

Fabiola Torres-Skair appeals the district court’s grant of summary judgment in favor of her former employer, Medco Health Solutions of Hidden River, LC (“Medco”), on her claims of pregnancy discrimination and retaliation under Title VII of the Civil Rights Act of 1964, 42 U.S.C. §§ 2000e-2(a), 2000e-3(a) and § 2000e(k) (“Title VII”), and the Florida Civil Rights Act (“FCRA”), Fla. Stat. § 760.10. In the district court, Torres-Skair claimed that Medco took three adverse employment actions against her because of her pregnancy: giving her a negative performance evaluation, placing her on administrative leave, and then terminating her employment. Medco asserted that the decisions were based solely on Torres-Skair’s violations of work policies. After careful review, we affirm.

I.

A. Factual Background

Medco is a third-party manager of prescription benefits for health insurers that provides prescription drugs by mail and prescription claims-processing services for insured persons. Torres-Skair began working for Medco as a clinical-care pharmacist in February 2009 at Medco’s center in Tampa, Florida, mostly working over the telephone.

Her primary job duties at Medco included counseling patients about medications and encouraging patients to sign up for mail-order prescription services provided by Medco, instead of buying their prescriptions at retail stores. With the pharmacists’ knowledge, Medco monitored their telephone calls. Torres-Skair’s direct supervisor at Medco was Yvette Powrie. Powrie, in turn, reported to Jennifer Nar-ducci, the director of the group in which Torres-Skair worked.

Torres-Skair began working from home in early 2010, using a computer, auto-dialer, and headset provided by Medco. While working at home, she had equipment trouble that persisted throughout her tenure.

Beginning in 2010, Medco for the first time instituted production quotas. Pharmacists in Torres-Skair’s group initially were expected to meet certain weekly goals for the number of prescriptions they converted from retail to mail order (“prescriptions per week”) and the rate at which they converted those prescriptions (“accept rate”). At some point in mid-2010, Medco added more goals relating to the number of calls pharmacists made (“green lights”) and the percentage of time they spent logged on but not actively on a call (“idle time”).

1. Medco Learns that Torres-Skair is Pregnant

Torres-Skair found out that she was pregnant sometime in October 2010. Before this time, management had had some *850 concern about Torres-Skair’s production. Without knowledge of Torres-Skair’s pregnancy, Powrie called Torres-Skair on October 29, 2010, and explained that her job performance was deficient, specifically with respect to her prescription numbers, and she identified several areas for improvement. After this discussion, but during the same telephone call, Torres-Skair told Powrie for the first time that she was pregnant. Powrie passed this information to Narducci two days later.

Beginning on January 1, 2011, Medco increased the prescriptions-per-week goal for all pharmacists in Torres-Skair’s group. Then, Narducci directed Powrie to develop plans to help certain employees, including Torres-Skair, achieve the new production requirements.

At about the same time, Torres-Skair informed Medco that she had been placed on certain medical restrictions by her physician. Powrie thereafter began to make comments to Torres-Skair regarding her pregnancy and related medical restrictions. Powrie stated that Torres-Skair was “moody,” “that [her] pregnancy was affecting [her] effectiveness,” “that the doctor’s notes that, [she] was giving were reducing [her] production” because they meant that Torres-Skair would not be able to be on the telephone as much as usual, and that she thought that Torres-Skair was “more moody than usual.” Powrie also told Greg Chavez, Powrie’s counterpart in Arizona, that Torres-Skair was pregnant.

2. The 2010 Annual Performance Evaluation

Torres-Skair received her 2010 performance evaluation from Powrie on March 9, 2011. According to Powrie’s evaluation, Torres-Skair was “consistently below the goals” for prescriptions per week, green lights, and idle time, and her performance had declined during the year. Powrie further stated that Torres-Skair’s “performance d[id] not meet expectations,” that it “require[d] improvement,” and that “[s]he displayed] a negative demeanor about the position” that came through occasionally on her calls. Due to the evaluation, Torres-Skair did not receive a bonus or stock opportunities with Medco.

Over the next several days, Torres-Skair filed anonymous complaints with Medco’s Ethics Hotline’s toll-free number about Powrie and Chavez, claiming that they had retaliated against her for expressing concerns about the job. 1 She also complained that Powrie told Chavez that Plaintiff was pregnant and hormonal. Medco investigated the complaint and did not find any retaliation.

3. Torres-Skair is Placed on Administrative Leave and then Discharged

Acting on a request from another Medco manager, who interacted with Torres-Skair’s group, Medco began investigating Torres-Skair’s sales calls in May 2011 to determine if she was “refaxing” prescription requests. • Refaxing occurred when a pharmacist faxed a request for a customer’s prescription to the customer’s physician after that same request had already been faxed, which resulted in a pharmacist receiving additional credit for the same prescription. According to Torres-Skair, this was common practice and condoned by Powrie, among others.

Another Medco manager, Brian Schumm — who also did not supervise Torres-Skair-conducted the research and re *851 viewed Torres-Skair’s sales calls for a one-week period in May 2011. From his research, Schumm observed the following relevant issues in Torres-Skair’s calls: (1) Torres-Skair disconnected a call with a customer; (2) she refaxed prescription requests instead of obtaining verbal orders from physicians; (3) she remained on the line for an excessive period of time without leaving a voicemail; and (4) she did not appear to be answering many of the calls that were being routed to her.

On May 18, 2011, Torres-Skair notified Powrie that she was contacting Medco’s third-party handler of claims under the Family and Medical Leave Act (“FMLA”), in anticipation of taking FMLA maternity leave.

Two days later, on May 20, 2011, Pow-rie, Narducci (Powrie’s supervisor), and Jennifer Bannon (a human resources manager), conducted a conference call with Torres-Skair regarding Schumm’s report of her sales calls. During the call, Torres-Skair was placed on administrative leave pending further investigation. After-wards, Torres-Skair called the Ethics Hotline and stated her belief that Narducci, Bannon, and Powrie were “building a case” to provide management reason to terminate her in order to deprive her of maternity-leave benefits.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In Re: Standard Jury Instructions in Civil Cases—report No. 16-01
214 So. 3d 552 (Supreme Court of Florida, 2017)
Diaz v. Florida
219 F. Supp. 3d 1207 (S.D. Florida, 2016)

Cite This Page — Counsel Stack

Bluebook (online)
595 F. App'x 847, Counsel Stack Legal Research, https://law.counselstack.com/opinion/fabiola-torres-skair-v-medco-health-solutions-of-hidden-river-lc-ca11-2014.